QBI and Director Krogan ’s COVID and infectious disease efforts continue to make waves

A study led by the labs of Nevan Krogan, PhD, director of the School ’s Quantitative Biosciences Institute (QBI) and senior investigator at Gladstone Institutes, was published online inCELL, reporting breakthrough findings on convergent evolutionary mechanisms shared by COVID-19 variants that allow them to overcome both adaptive and innate immune system barriers.
Source: UCSF School of Pharmacy News - Category: Universities & Medical Training Source Type: news